Clinical Trial: Low Back Pain Patient Education Evaluation

This study has been completed.

Sponsored by: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Information provided by: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Purpose

Back pain is one of the most common of all symptoms. It is also a great cause of days lost from work and visits to health care providers. This study will develop and evaluate an approach to low back pain that allows subjects to talk with each other and with health professionals via an Internet discussion group. Results we will look at include health behaviors, such as exercise; health status, such as pain and disability; and health care use, such as number of visits to doctors and other health care providers. Anyone 18 years old or older who lives in the United States and has ongoing Internet access can take part in the study. All subjects must have back pain and meet the eligibility criteria listed below.

Condition Treatment or Intervention Phase
Low Back Pain
 Procedure: Patient education evaluation
Phase III

MedlinePlus related topics:  Back Pain

Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study

Official Title: Evaluation of a Low Back Pain Patient Education Program

Further Study Details: 

Expected Total Enrollment:  580

Study start: February 1998;  Study completion: January 2002

This study will develop and evaluate in a randomized trial a low back pain intervention that allows subjects to talk with each other and with health professionals via an Internet discussion group. The intervention consists of a book and a videotape and is based on interaction with other participants in the program and health professionals through a closed password protected moderated Internet discussion group. Outcome measures include health behaviors, such as exercise; health status, such as pain and disability; and health care use, such as number of visits to doctors and other health care providers. Patients will be randomized either to the treatment group and followed for 6, 12, 18, and 24 months with the intervention.

Eligibility

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

  • Must live in the United States
  • Must understand and write English
  • Must have access to a computer with e-mail and expect to have this access for at least 3 years
  • Must be 18 years old
  • Must have seen a doctor for back pain at least once in the past year

Exclusion Criteria:

  • Pregnancy
  • Back surgery in the past 6 months
  • Expectation of having back surgery in the next 6 months
  • Back pain due to a car accident or other major injury within the last 6 months
  • Back pain or sciatica due to systemic disease (inflammatory rheumatic diseases, tumor, or other)
  • Major physical or mental health condition for which one is currently being treated that severely limits daily activities
  • Terminal illness
  • Receiving disability or workers compensation insurance payments for back pain or sciatica
  • Presently involved in legal proceedings because of back pain or sciatica
  • Difficulty with bladder or bowel control that began with back pain or sciatica
  • No visits to a doctor in the past year for back pain or sciatica
  • Numbness in crotch area that began with back pain or sciatica
  • Age under 18

Location Information


California
      Stanford University, Palo Alto,  California,  94305,  United States

Study chairs or principal investigators

Kate R. Lorig, Dr.P.H.,  Principal Investigator,  Stanford University   

More Information

Publications

Lorig KR, Laurent DD, Deyo RA, Marnell ME, Minor MA, Ritter PL. Can a Back Pain E-mail Discussion Group improve health status and lower health care costs?: A randomized study. Arch Intern Med. 2002 Apr 8;162(7):792-6.

Study ID Numbers:  NIAMS-002; R01 AR44939
Record last reviewed:  February 2003
Last Updated:  October 13, 2004
Record first received:  November 3, 1999
ClinicalTrials.gov Identifier:  NCT00000408
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Resources